Payment overview · 2025
General Payments
$71.14
3 reported records · 2 companies
Healthcare provider profile · identity verified
Alan Bart Mickish, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · EASTLAND, TX · NPI 1215045240
Verified facts
What the public records show
CMS Open Payments records show Alan Bart Mickish, M.D. received $71.14 in general payments during 2025 across 3 reported records.
Corcept Therapeutics accounted for 74.9% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Corcept Therapeutics | Unresolved — no canonical attribution shown | $53.31 | 74.9% | 2 | 2025 |
| Sumitomo Pharma America, Inc. | Unresolved — no canonical attribution shown | $17.83 | 25.1% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $71.14 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Korlym Normalized: korlym |
Drug | Corcept Therapeutics | $53.31 | 2 | 2025 |
Source payment records
|
|||||
| GEMTESA Normalized: gemtesa |
Drug | Sumitomo Pharma America, Inc. | $17.83 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 560 | 86 |
| Atorvastatin Calcium | Atorvastatin Calcium | 428 | 92 |
| Amlodipine Besylate | Amlodipine Besylate | 348 | 64 |
| Gabapentin | Gabapentin | 340 | 65 |
| Lisinopril | Lisinopril | 334 | 76 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 294 | 70 |
| Losartan Potassium | Losartan Potassium | 249 | 57 |
| Celecoxib | Celecoxib | 215 | 41 |
| Metoprolol Succinate | Metoprolol Succinate | 215 | 36 |
| Furosemide | Furosemide | 201 | 38 |
| Tamsulosin Hcl | Tamsulosin Hcl | 185 | 40 |
| Metformin Hcl | Metformin Hcl | 178 | 39 |
| Baclofen | Baclofen | 163 | 44 |
| Metoprolol Tartrate | Metoprolol Tartrate | 161 | 25 |
| Hydrochlorothiazide | Hydrochlorothiazide | 159 | 38 |
| Pantoprazole Sodium | Pantoprazole Sodium | 156 | 32 |
| Eliquis | Apixaban | 131 | 28 |
| Allopurinol | Allopurinol | 130 | 25 |
| Meloxicam | Meloxicam | 130 | 27 |
| Clopidogrel | Clopidogrel Bisulfate | 119 | 20 |
| Omeprazole | Omeprazole | 119 | 26 |
| Mounjaro | Tirzepatide | 117 | 19 |
| Potassium Chloride | Potassium Chloride | 115 | 24 |
| Ozempic | Semaglutide | 112 | 26 |
| Escitalopram Oxalate | Escitalopram Oxalate | 109 | 21 |
| Mirtazapine | Mirtazapine | 109 | 19 |
| Spironolactone | Spironolactone | 108 | 18 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 97 | 18 |
| Chlorthalidone | Chlorthalidone | 96 | 27 |
| Bupropion Hcl Sr | Bupropion Hcl | 90 | 20 |
| Trazodone Hcl | Trazodone Hcl | 90 | 14 |
| Citalopram Hbr | Citalopram Hydrobromide | 89 | 17 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 83 | 21 |
| Carvedilol | Carvedilol | 81 | 15 |
| Clonazepam | Clonazepam | 81 | 19 |
| Simvastatin | Simvastatin | 78 | 16 |
| Memantine Hcl | Memantine Hcl | 75 | 11 |
| Azelastine Hcl | Azelastine Hcl | 73 | 57 |
| Donepezil Hcl | Donepezil Hcl | 73 | 16 |
| Zonisamide | Zonisamide | 71 | 17 |
| Tresiba Flextouch U-100 | Insulin Degludec | 67 | 14 |
| Montelukast Sodium | Montelukast Sodium | 64 | 12 |
| Buspirone Hcl | Buspirone Hcl | 63 | 12 |
| Xarelto | Rivaroxaban | 62 | suppressed |
| Synthroid | Levothyroxine Sodium | 60 | 13 |
| Duloxetine Hcl | Duloxetine Hcl | 59 | 12 |
| Clonidine Hcl | Clonidine Hcl | 57 | 16 |
| Nebivolol Hcl | Nebivolol Hcl | 57 | suppressed |
| Ezetimibe | Ezetimibe | 54 | 15 |
| Telmisartan | Telmisartan | 54 | 11 |
| Fluoxetine Hcl | Fluoxetine Hcl | 52 | suppressed |
| Eszopiclone | Eszopiclone | 51 | 13 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 51 | 13 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 48 | 18 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 48 | suppressed |
| Myrbetriq | Mirabegron | 48 | 14 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 47 | 13 |
| Alendronate Sodium | Alendronate Sodium | 46 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 43 | 11 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 43 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 42 | 15 |
| Sertraline Hcl | Sertraline Hcl | 42 | 12 |
| Tresiba Flextouch U-200 | Insulin Degludec | 42 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 41 | 15 |
| Sucralfate | Sucralfate | 40 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 38 | suppressed |
| Azithromycin | Azithromycin | 37 | 30 |
| Lamotrigine | Lamotrigine | 37 | suppressed |
| Levofloxacin | Levofloxacin | 37 | 18 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 36 | suppressed |
| Mupirocin | Mupirocin | 36 | 29 |
| Pravastatin Sodium | Pravastatin Sodium | 35 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 34 | 14 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 33 | 28 |
| Divalproex Sodium | Divalproex Sodium | 32 | suppressed |
| Ramipril | Ramipril | 32 | suppressed |
| Atenolol | Atenolol | 31 | suppressed |
| Glipizide | Glipizide | 31 | suppressed |
| Ondansetron Odt | Ondansetron | 31 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 29 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 28 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 28 | 18 |
| Hydralazine Hcl | Hydralazine Hcl | 28 | suppressed |
| Levetiracetam | Levetiracetam | 28 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 28 | 12 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 28 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 27 | 13 |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 26 | suppressed |
| Famotidine | Famotidine | 26 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 26 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 26 | 13 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 26 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 26 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 25 | suppressed |
| Pregabalin | Pregabalin | 25 | suppressed |
| Finasteride | Finasteride | 24 | suppressed |
| Glimepiride | Glimepiride | 24 | suppressed |
| Jardiance | Empagliflozin | 24 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 24 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 22 | 17 |
| Warfarin Sodium | Warfarin Sodium | 22 | suppressed |
| Bupropion Xl | Bupropion Hcl | 21 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 21 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 21 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 21 | suppressed |
| Ranolazine Er | Ranolazine | 21 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 21 | suppressed |
| Temazepam | Temazepam | 21 | suppressed |
| Cephalexin | Cephalexin | 20 | 13 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 20 | suppressed |
| Edarbi | Azilsartan Medoxomil | 20 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 20 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 20 | 12 |
| Ziprasidone Hcl | Ziprasidone Hcl | 20 | suppressed |
| Digoxin | Digoxin | 19 | suppressed |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 19 | suppressed |
| Primidone | Primidone | 19 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 19 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 18 | suppressed |
| Alprazolam | Alprazolam | 17 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 17 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 17 | suppressed |
| Tramadol Hcl-Acetaminophen | Tramadol Hcl/Acetaminophen | 17 | 15 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 16 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 16 | suppressed |
| Fenofibric Acid | Fenofibric Acid (Choline) | 16 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 15 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 15 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 14 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 14 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 14 | suppressed |
| Nitroglycerin | Nitroglycerin | 14 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 14 | 14 |
| Telmisartan-Hydrochlorothiazid | Telmisartan/Hydrochlorothiazid | 14 | suppressed |
| Calcitriol | Calcitriol | 13 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 13 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 13 | suppressed |
| Prednisone | Prednisone | 13 | suppressed |
| Premarin | Estrogens, Conjugated | 13 | suppressed |
| Xigduo Xr | Dapaglifloz Propaned/Metformin | 13 | suppressed |
| Bydureon Bcise | Exenatide Microspheres | 12 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 12 | suppressed |
| Famciclovir | Famciclovir | 12 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 12 | suppressed |
| Irbesartan | Irbesartan | 12 | suppressed |
| Lisdexamfetamine Dimesylate | Lisdexamfetamine Dimesylate | 12 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 12 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 11 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 11 | suppressed |
| Fluconazole | Fluconazole | 11 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 11 | suppressed |
| Methocarbamol | Methocarbamol | 11 | suppressed |
| Nifedipine Er | Nifedipine | 11 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 11 | suppressed |
| Valsartan | Valsartan | 11 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $71.14 · 3 records | Corcept Therapeutics | GEMTESA, Korlym | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error